Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

類似資料

• Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis
  著者:: Gudesblatt, Mark, 等
  出版事項: (2018)
• Utility of the NeuroTrax Computerized Battery for Cognitive Screening in Parkinson's Disease: Comparison with the MMSE and the MoCA
  著者:: Hanna-Pladdy, B., 等
  出版事項: (2010)
• Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE
  著者:: Perumal, Jai, 等
  出版事項: (2019)
• Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study
  著者:: Wilken, Jeffrey, 等
  出版事項: (2013)
• Natalizumab for the treatment of relapsing multiple sclerosis
  著者:: Rudick, Richard A, 等
  出版事項: (2008)